Department of Medicine, McMaster University, Hamilton, Ontario, Canada
School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
BMJ Open. 2024 Apr 10;14(4):e079750. doi: 10.1136/bmjopen-2023-079750.
Metabolic dysfunction-associated fatty liver disease (MASLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease worldwide. Given that there is no pharmacological treatment for MASLD, it is imperative to understand whether lifestyle modifications may improve biochemical and pathological outcomes. One commonly proposed dietary modification is the Mediterranean diet; however, vegetarianism may also be a promising intervention. Vegetarianism has been shown to be associated with reduced morbidity and mortality in metabolic syndrome outcomes in coronary artery disease and diabetes; however, the relationship between vegetarian diet and MASLD is less clear. In this scoping review, we will provide a comprehensive overview of the current body of evidence related to a vegetarian diet and MASLD.
The aim of this scoping review is to describe and summarise the current body of evidence related to MASLD and a vegetarian diet. This review will be conducted using Arksey and O'Malley's framework. The literature review will be conducted using the following databases: SCOPUS, Web of Science, CINAHL-Plus, Cochrane Library and Medline. No restriction will be made on publication date. Included studies will encompass clinical trials and observational designs that examine effects or association of vegetarian diet in adults (≥16 years) and report on the incidence, prevalence or progression of MASLD. Grey literature, non-human studies and articles focusing on changes in a specific food or nutraceutical will be excluded. Articles must have an English-language abstract available to be considered for inclusion. Screening and data extraction will be conducted by two independent reviewers. The findings will be summarised with descriptive statistics.
Approval from a medical ethics committee is not required for this review. Once the review is complete, the findings will be submitted to a peer-reviewed journal.
代谢相关脂肪性肝病(MASLD)是代谢综合征的肝脏表现,也是全球慢性肝病的主要病因。鉴于目前尚无针对 MASLD 的药物治疗方法,了解生活方式的改变是否可以改善生化和病理结果至关重要。一种常见的饮食调整方法是地中海饮食;然而,素食也可能是一种有前途的干预措施。素食已被证明与冠心病和糖尿病代谢综合征结果的发病率和死亡率降低有关;然而,素食与 MASLD 之间的关系尚不清楚。在本范围综述中,我们将全面概述与素食和 MASLD 相关的现有证据。
本范围综述的目的是描述和总结与素食和 MASLD 相关的现有证据。本综述将使用 Arksey 和 O'Malley 的框架进行。文献综述将使用以下数据库进行:Scopus、Web of Science、CINAHL-Plus、Cochrane 图书馆和 Medline。不限制出版日期。纳入的研究将包括临床试验和观察性设计,这些设计检查了素食对成年人(≥16 岁)的影响或关联,并报告 MASLD 的发生率、患病率或进展。将排除灰色文献、非人类研究和专注于特定食物或营养保健品变化的文章。只有具有英文摘要的文章才能被考虑纳入。筛选和数据提取将由两名独立的审查员进行。将使用描述性统计数据总结研究结果。
本综述不需要医学伦理委员会的批准。审查完成后,研究结果将提交给同行评议的期刊。